Keywords = sCD163
| Number of Articles: 3 | ||
| 1 | Serum Soluble CD163 as a Marker of Activity in MS Patients | |
| Volume 90, Issue 6, June 2022, Page 1039-1045 | ||
| MARWA R. EL NAJJAR, M.D.; MONA M. RAFIK, M.D.; DINA A. SOLIMAN, M.D.; EMAN A.M. HASSAN, M.Sc.; ALAA M. ABOU STEIT, M.D. | ||
| 2 | Serum soluble cluster of differentiation 163 (sCD163), matrix metalloproteinase 9 (MMP9) and cytokeratin 18 (CK18) levels as biomarkers for liver fibrosis in Egyptian chronic hepatitis C patients | |
| Volume 59, Issue 1, January 2021, Page 9-19 | ||
| Shaimaa Mahmoud; Rania Mohmed; Amin Abd El Baki; Eman Abdel Azeem; Eman Saleh | ||
| 3 | Soluble CD163 as a surrogate marker of fibrosis regression in chronic HCV patients receiving direct antiviral agents | |
| Volume 6, Issue 7, November 2019, Page 43-55 | ||
| Amira Isaac; Ahmed Aly Mo'nes; Wesam Essam Aly Wassfy; Hesham Hamdy El-Kilany | ||
View on SCiNiTO